Pro Share Advisors LLC Atreca, Inc. Transaction History

Pro Share Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.91 - $9.07 $59,710 - $110,300	-12,161 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$7.82 - $13.8 $2,330 - $4,112	298 Added 2.51%	12,161 $104,000
Q1 2021 May 14, 2021	BUY	$13.0 - $19.34 $11,128 - $16,555	856 Added 7.78%	11,863 $182,000
Q4 2020 Feb 09, 2021	BUY	$13.03 - $17.09 $143,421 - $188,109	11,007 New	11,007 $178,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.